Skip to main content
SpringerLink
Log in

Doxazosin—an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (BPH) (part two)

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

This part of our study presents results of laboratory evaluations in patients with BPH during treatment with prazosin and doxazosin. After 72 weeks serum PSA and PAP fell by 40.2% and 82%, respectively. Blood urea nitrogen concentration decreased by 28.5% and serum creatinine by 20.8%. The results confirm long-term favourable effects of the therapy of patients with BPH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dutkiewicz, S.: Treatment of prostatic adenoma with use of Minipress (in Polish).Ter. Leki, 6, 107 (1989).

    Google Scholar 

  2. Dyniewska-Adamska, H.: Doxazosin—a hypotensive drug (in Polish).Probl. Terap. Monitor., 2/3, 73 (1991).

    Google Scholar 

  3. Pool, J.: Effects of doxazosin on serum lipids: A review of the clinical data and molecular basis for altered lipid metabolism.Am. Heart J., 121, 251 (1991).

    Article  PubMed  CAS  Google Scholar 

  4. Young, R., Brogden, R.: Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in mild or moderate hypertension.Drugs, 35, 525 (1988).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Ministry of Internal Affairs Central Clinical Hospital, Warsaw, Poland

    S. Dutkiewicz, A. Witeska & K. Stępień

Authors
  1. S. Dutkiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Witeska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Stępień
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

As described in Part One, Vol. 27, No. 3 (1995).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dutkiewicz, S., Witeska, A. & Stępień, K. Doxazosin—an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (BPH) (part two). International Urology and Nephrology 27, 413–417 (1995). https://doi.org/10.1007/BF02550076

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550076

Keywords

Search

Navigation